October 2016

Current versions by ASCO, NCCN, and others may not be right for insurers, but they are eyeing new ways to crunch the numbers for cost and outcomes.
Ed Silverman
Experts are rethinking the routine cancer screen. In the future, screening recommendations may be tailored, risk-stratified, and based on our genes.
Charlotte Huff
Patients and doctors are fighting the urge to rush in and treat cancer right away. Insurers must walk a fine line.
Richard Mark Kirkner


Legislation & Regulation: Campaign 2016
The fate of the health care reform law will be determined by the outcome of a joyless election.
Richard Mark Kirkner